Business

Approval of 3AEY in Italy

Approval of 3AEY in Italy.

articleEden Research PlcFebruary 11, 20165/company/eden-research-plc/news/approval-of-3aey-in-italy
Approval of 3AEY in Italy

About this update from Eden Research Plc

[{"type":"text","content":"\n \nRNS Number : 7219O Eden Research plc 11 February 2016  \n\nEden Research Plc\n(\"Eden\" or \"Company\")\n \nApproval of 3AEY in Italy \n \nEden Research plc (AIM: EDEN), the AIM-listed company that provides breakthrough natural microencapsulation technologies to the global agrochemicals, animal health and consumer products industries, announces that is has now received authorisation in Italy for its first product, 3AEY, for use in the prevention and treatment of botrytis in table and wine grapes. 3AEY will be sold in Italy by Eden partner Sipcam S.p.A. under the brand name \"3LOGY™\" following the issuance of the registration number by the Italian authorities.\n \nThis is a significant and long-awaited milestone for the Company and will allow Sipcam to sell 3LOGY to its established customers. 3LOGY is a terpene-based fungicide that can treat and prevent botrytis. Botrytis is a widespread fungal disease that causes grey mould on many fruits and vegetables leading to the rapid loss of commercially valuable crops. The average losses from affected crops account for around 20% of the total harvest, costing producers between €10-100 billion annually worldwide, depending upon weather conditions. The market for Botryticides alone is approximately $300m per annum.\n \nSean Smith, Chief Executive Officer of Eden, said: \"Italy has recently become the largest wine producing country in the world, and so to have 3LOGY registered and available for sale in this important market is clearly very good news for Eden, our partners and the grape growers in Italy. Since we signed the licence agreement with Sipcam in November 2014, there has been a lot of work by both parties to ensure that we could meet the 2016 growing season and to demonstrate the benefits of 3LOGY to growers and distributors.\n \n\"Following marketing trials undertaken in 2015, 3LOGY has been very well received by customers throughout the EU southern zone. The unique characteristics that 3LOGY has in terms of its safety and environmental profile, good efficacy and exemption from Maximum Residue Limits make it an interesting and useful product for growers to use. This is particularly relevant in the late stages of the growing season when botrytis can be prevalent and where many alternative products are not able to be used due to residue issue...

More updates from Eden Research Plc